Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 11, 2025Journal of Oncology Pharmacy PracticeOpen Access

An evaluation of a real-world, multi-disciplinary, treatment-free remission programme for patients with Chronic Myeloid Leukaemia

View Full Paper
Ask AI
Bookmark
Share

Authors

EJEleanor JonesJEJoanne EwingHHHayder Hussein

Discussion

Loading...

Member takes

Overview

Retrospective cohort study found 70.3% success in treatment-free remission for CML patients, suggesting effective multidisciplinary support.

Key Points

  • Overall success rate of achieving treatment-free remission was 70.3% for patients with chronic myeloid leukaemia in the study.
  • Patients meeting international TFR eligibility guidelines had a higher success rate of 77% compared to 55% for those who did not.
  • A retrospective cohort study collected data on patients attempting TFR from January 2016 to August 2024 in a UK centre.
  • Multidisciplinary monitoring ensured that follow-up requirements were met for almost all participants, demonstrating effectiveness.

Cite This Study

Jones et al. (2025) studied this question.

synapsesocial.com/papers/68e9b1d9ba7d64b6fc132d55https://doi.org/10.1177/10781552251384611
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Real-World Evidence-Based Study on Treatment-Free Remission in Chronic Myeloid Leukemia2026
  2. 2Durable treatment-free remission in CML beyond clinical trials: Lessons from a large single-center real-world experience.2026
  3. 3TKI Use and Treatment-Free Remission in Chronic Myeloid Leukemia: Evidence from a Regional Cohort Study in the Canary Islands2025
  4. 4Treatment-Free Remission in Chronic Myeloid Leukemia: Can We Identify Prognostic Factors?2021 · 20 citations
  5. 5Treatment-Free Remission in Chronic Myeloid Leukemia2024 · 18 citations